https://www.lifesciencelaw.ch/news/2024-05-24_regulatory-beyond-2024-save-the-date2026-10-23T18:12:20+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-24_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-13-16-may-20242026-10-23T18:12:19+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-24_medical-devices-new-guidance-for-industry-and-notified-bodies2026-10-23T18:12:19+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-24_decision-c-2364-2021-of-24-april-20242026-10-23T18:30:22+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-24_decision-a-1004-2023-of-7-may-20242026-10-23T18:12:18+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-17_womens-health-needs-require-more-thorough-consideration2026-10-23T18:12:17+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-10_federal-council-wants-to-improve-working-conditions-and-education-for-nursing-professionals2026-10-23T18:12:16+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-10_first-monitoring-report-on-the-new-regulation-of-psychological-psychotherapy2026-10-23T18:12:16+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-10_hpc-mydocalm-tolperisone2026-10-23T18:12:15+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-10_swissmedic-journal-04-20242026-10-23T18:12:15+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-10_one-health-a-joint-framework-for-action-published-by-five-eu-agencies2026-10-23T18:12:14+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-10_decision-9c-201-2023-of-3-april-20242026-10-23T18:12:14+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-03_objection-regulation-for-organ-donation-opening-of-the-consultation-procedure2026-10-23T18:12:13+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-03_tariff-negotiations-for-analysis-list-federal-council-adopts-dispatch2026-10-23T18:12:13+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-03_federal-council-receives-report-on-the-implementation-of-the-revised-system-of-care-financing2026-10-23T18:12:12+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-03_hpc-medicinal-products-containing-pseudoephedrine2026-10-23T18:12:12+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-03_meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-22-25-april-20242026-10-23T18:12:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-05-03_decision-c-2733-2021-of-23-april-20242026-10-23T18:12:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-26_oral-methotrexate-and-risk-of-unintentional-overdose-due-to-medication-errors2026-10-23T18:12:10+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-26_swissmedic-participation-at-swiss-biotech-day-in-basel2026-10-23T18:12:09+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-26_new-recommendations-to-strengthen-supply-chains-of-critical-medicines2026-10-23T18:12:09+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-26_decision-9c-65-2023-of-18-march-20242026-10-23T18:12:08+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-19_adjustment-of-the-distribution-share-foph-circular-733-4-15-12026-10-23T18:12:08+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-19_federal-office-of-public-health-new-head-of-international-affairs-division2026-10-23T18:12:07+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-19_products-containing-cannabidiol-cbd-and-other-cannabinoids-that-are-not-subject-to-narcotics-legislation2026-10-23T18:12:07+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-19_swissmedic-receives-grant-from-the-bill-melinda-gates-foundation2026-10-23T18:12:06+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-19_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-8-11-april-20242026-10-23T18:12:06+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-19_covid-19-vaccine-strain-updates-global-regulators-agree-on-timing-and-data-requirements2026-10-23T18:12:05+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-19_decision-9c-126-2023-of-4-march-20242026-10-23T18:12:05+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-12_the-federal-council-recommends-rejecting-the-compulsory-health-insurance-premium-relief-initiative-praemien-entlastungs-initiative2026-10-23T18:12:04+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-12_the-federal-council-recommends-rejecting-the-cost-control-initiative-kostenbremse-initiative2026-10-23T18:12:03+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-12_the-federal-council-recommends-rejecting-the-popular-initiative-for-freedom-and-physical-integrity-volksinitiative-fuer-freiheit-und-koerperliche-unversehrtheit2026-10-23T18:12:03+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-12_decision-c-2370-2021-of-20-march-20242026-10-23T18:12:02+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-05_increased-retention-fee-for-medicinal-products2026-10-23T18:12:02+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-05_hpc-opioids-boxed-warning2026-10-23T18:12:01+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-05_swissmedic-journal-03-20242026-10-23T18:12:01+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-05_decision-9c-162-2023-of-12-march-20242026-10-23T18:12:00+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-04-05_decision-9c-637-2023-of-18-march-20242026-10-23T18:12:00+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-08_decision-c-1664-2019-of-29-january-20242026-10-23T18:11:59+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-29_historic-recognition-of-harm-reduction-principle-at-the-un-commission-on-narcotic-drugs2026-10-23T18:11:59+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-29_the-federal-council-adopts-goals-for-quality-development-in-health-insurance2026-10-23T18:11:58+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-29_swissmedic-warns-against-illegal-medicinal-product-lemon-bottle-lipolysis-solution2026-10-23T18:11:58+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-29_eu-recommendations-for-2024-2025-seasonal-flu-vaccine-composition2026-10-23T18:11:57+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-29_meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-18-21-march-20242026-10-23T18:11:57+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-29_first-oral-monotherapy-for-patients-with-paroxysmal-nocturnal-haemoglobinuria2026-10-23T18:11:56+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-29_new-antibiotic-to-fight-infections-caused-by-multidrug-resistant-bacteria2026-10-23T18:11:56+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-29_regulatory-information-adjusted-fees-for-applications-to-ema-from-1-april-20242026-10-23T18:11:55+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-29_decision-9c-562-20232026-10-23T18:11:55+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-29_current-legal-developments-in-the-healthcare-sector2026-10-23T18:30:23+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-29_product-recall-2024-chapter-switzerland2026-10-23T18:30:23+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-22_decision-2c-537-2022-of-25-january-20242026-10-23T18:11:53+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-22_overview-of-health-insurance-figures2026-10-23T18:11:53+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-22_extension-of-the-deadline-for-setting-the-tariff-for-outpatient-physiotherapy-services2026-10-23T18:11:52+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-22_accelerating-stakeholder-collaboration-to-enhance-the-clinical-trials-environment-in-the-eu2026-10-23T18:11:52+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-15_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-4-7-march-20242026-10-23T18:11:51+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-15_decision-149-ii-381-of-18-september-20232026-10-23T18:11:51+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-15_european-court-of-justice-decision-c-291-22-p-of-14-march-20242026-10-23T18:11:50+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-08_canton-of-zurich-implementation-of-new-admission-restrictions-suspended-for-the-time-being2026-10-23T18:11:50+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-08_fennel-tea-for-pregnant-women-infants-and-children-under-4-years2026-10-23T18:11:49+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-08_swissmedic-journal-02-20242026-10-23T18:11:49+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-08_new-authorisations-of-complementary-and-herbal-medicines2026-10-23T18:11:48+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-08_public-consultation-on-ich-guideline-e2dr1-launched-in-switzerland2026-10-23T18:11:48+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-08_darwin-eu-continues-expanding-its-capacity-to-deliver-real-world-data-studies2026-10-23T18:11:47+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-08_decision-c-271-2021-of-5-february-20242026-10-23T18:11:47+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-08_decision-9c-721-2023-of-15-february-20242026-10-23T18:11:46+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-01_swissmedic-podcast-focus-on-therapeutic-products2026-10-23T18:11:45+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-01_meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-19-22-february-20242026-10-23T18:11:45+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-01_new-treatment-for-rare-motor-neurone-disease-recommended-for-approval2026-10-23T18:11:44+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-01_first-oral-treatment-against-residual-haemolytic-anaemia-in-patients-with-paroxysmal-nocturnal-haemoglobinuria2026-10-23T18:11:44+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-03-01_european-court-of-justice-decision-c-606-21-of-29-february-20242026-10-23T18:11:43+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-23_new-publication-cannabis-a-handbook-for-science-and-practice2026-10-23T18:11:42+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-23_national-health-conference-2030-under-the-banner-of-digitalisation2026-10-23T18:11:42+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-16_authorisations-of-human-medicinal-products-with-a-new-active-substance-and-additional-indications-20232026-10-23T18:11:41+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-16_launch-of-new-hma-ema-catalogues-of-real-world-data-sources-and-studies2026-10-23T18:11:41+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-16_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-5-8-february-20242026-10-23T18:11:40+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-16_decision-9c-135-2022-of-12-december-20232026-10-23T18:11:40+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-09_infections-in-swiss-hospitals-are-to-be-significantly-reduced2026-10-23T18:11:39+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-05_swissmedic-journal-01-20242026-10-23T18:11:39+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-09_illegal-imports-of-medicinal-products-erectile-stimulants-account-for-more-than-two-thirds2026-10-23T18:11:38+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-09_progress-update-on-pilot-for-academic-and-non-profit-developers-of-advanced-therapy-medicines2026-10-23T18:11:38+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-02_improving-addiction-support-and-care-urgently-needed2026-10-23T18:11:37+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-02_clinical-trials-transition-to-new-eu-system-one-year-left2026-10-23T18:11:37+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-02_the-european-medicines-agency-ema-to-support-establishment-of-the-african-medicines-agency2026-10-23T18:11:36+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-02-02_precautionary-measures-to-address-potential-risk-of-neurodevelopmental-disorders-in-children-born-to-men-treated-with-valproate-medicines2026-10-23T18:11:36+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-26_elisabeth-baume-schneider-at-oecd-health-ministerial-meeting-in-paris2026-10-23T18:11:35+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-26_organ-donation-figures-for-2023-in-switzerland-reach-a-new-record-high2026-10-23T18:11:35+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-26_major-update-of-the-user-guide-for-micro-small-and-medium-sizes-enterprises-smes2026-10-23T18:11:34+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-26_stepping-into-the-future-a-closer-look-at-the-third-revision-of-the-therapeutic-products-act-tpa2026-10-23T18:30:23+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-19_quality-information-on-healthcare-how-can-a-platform-with-added-value-for-the-public-succeed2026-10-23T18:11:33+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-19_guidance-document-authorisation-according-to-art-14-para-1-abis-quater-of-the-therapeutic-products-act-tpa-updated-22026-10-23T18:11:33+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-19_authorisation-of-immunological-veterinary-medicinal-products-in-the-event-of-an-epizootic-outbreak2026-10-23T18:11:32+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-19_changes-to-the-guidance-document-fast-track-authorization-procedure2026-10-23T18:11:32+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-19_changes-to-the-guidance-document-temporary-authorization-of-human-medicinal-products2026-10-23T18:11:31+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-19_changes-to-guidance-document-authorisation-of-human-medicinal-product-with-known-active-pharmaceutical-ingredient2026-10-23T18:11:31+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-19_potential-risk-of-neurodevelopmental-disorders-in-children-born-to-men-treated-with-valproate-medicines-prac-recommends-precautionary-measures2026-10-23T18:11:30+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-19_decision-9c-222-2023-of-18-december-20232026-10-23T18:11:30+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-12_medicinal-products-important-update-for-insured-individuals-from-january-20242026-10-23T18:11:29+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-12_the-swiss-federal-audit-office-sfao-gives-swissmedic-a-doubly-good-report2026-10-23T18:11:28+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-09_swissmedic-journal-12-20232026-10-23T18:11:28+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-05_federal-quality-commission-federal-council-approves-the-annual-goals-for-20242026-10-23T18:11:27+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-05_identification-of-medicinal-products2026-10-23T18:11:27+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-05_synapse-labs-pvt-ltd-the-european-medicines-agency-recommends-suspension-of-medicines-over-flawed-studies2026-10-23T18:11:26+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-05_new-treatment-for-young-children-with-parasitic-disease-schistosomiasis2026-10-23T18:11:26+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-05_the-european-medicines-agency-confirms-recommendation-for-non-renewal-of-authorisation-of-multiple-myeloma-medicine-blenrep2026-10-23T18:11:25+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-05_first-gene-editing-therapy-to-treat-beta-thalassemia-and-severe-sickle-cell-disease2026-10-23T18:11:25+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-05_artificial-intelligence-workplan-to-guide-use-of-ai-in-medicines-regulation2026-10-23T18:11:24+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-05_new-guidance-document-import-of-a-human-medicinal-product-according-to-art-14-para-2-and-3-of-the-therapeutic-products-act-parallel-import2026-10-23T18:11:24+02:00weekly0.5https://www.lifesciencelaw.ch/news/2024-01-05_implementation-of-the-european-pharmacopoeia-supplement-11-32026-10-23T18:11:23+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-15_extension-of-tariff-agreements-for-pharmacist-services-and-neuropsychology2026-10-23T18:11:22+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-15_for-more-transparency-in-data-management-in-the-healthcare-sector2026-10-23T18:11:21+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-15_revision-of-the-therapeutic-product-act-enhances-medication-safety2026-10-23T18:11:21+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-15_promotion-of-generics-and-price-reduction-for-medicinal-products2026-10-23T18:11:20+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-15_global-regulators-strengthen-efforts-to-ensure-continuous-availability-of-safe-and-high-quality-medicines2026-10-23T18:11:20+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-15_first-version-of-the-union-list-of-critical-medicines-agreed-to-help-avoid-potential-shortages-in-the-european-union2026-10-23T18:11:19+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-11_decision-c-2105-2022-of-29-november-20232026-10-23T18:11:19+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-08_the-government-includes-preventive-measures-against-breast-and-ovarian-cancer-in-the-basic-health-insurance-benefits-catalog2026-10-23T18:11:18+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-08_the-majority-of-the-swiss-population-is-satisfied-with-healthcare2026-10-23T18:11:18+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-06_swissmedic-journal-11-20232026-10-23T18:11:17+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-08_european-union-medicines-agencies-reflect-on-lessons-learned-from-covid-192026-10-23T18:11:17+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-24_decision-c-4921-2021-of-6-october-20232026-10-23T18:11:16+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-01_revision-of-the-epidemics-act-for-better-management-of-future-health-crises2026-10-23T18:11:15+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-01_covid-19-the-federal-government-covers-the-costs-of-vaccination-until-mid-20242026-10-23T18:11:15+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-01_information-system-for-notifiable-diseases-becomes-more-efficient2026-10-23T18:11:14+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-01_federal-council-adopts-vaccine-strategy-for-crisis-periods2026-10-23T18:11:14+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-01_warning-about-imports-of-melatonin-and-the-adrenal-hormone-dehydroepiandrosterone-dhea-by-private-individuals2026-10-23T18:11:13+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-12-01_swissmedic-vigilance-news-edition-31-november-20232026-10-23T18:11:13+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-13_decision-c-5955-2019-of-28-january-20222026-10-23T18:11:12+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-15_decision-c-4589-2020-of-30-october-20232026-10-23T18:11:12+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-24_the-federal-government-will-continue-measures-against-female-genital-mutilation2026-10-23T18:11:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-24_more-efficient-assistance-in-reducing-debts-for-minors-and-other-insured-individuals2026-10-23T18:11:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-24_compensation-for-asbestos-victims-opening-of-consultation2026-10-23T18:11:10+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-24_health-insurance-for-incarcerated-individuals-the-federal-council-initiates-the-consultation-procedure2026-10-23T18:11:10+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-24_federal-council-approves-three-tariff-structures-in-inpatient-care2026-10-23T18:11:09+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-24_amateur-sports-clubs-receive-financial-relief-in-accident-insurance2026-10-23T18:11:09+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-02_decision-c-5986-20192026-10-23T18:11:08+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-17_preventing-infections-to-ensure-the-long-term-effectiveness-of-antibiotics2026-10-23T18:11:08+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-17_risk-reduction-for-biocidal-products2026-10-23T18:11:07+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-17_military-insurance-federal-council-sets-premiums-for-20242026-10-23T18:11:07+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-10_swissmedic-journal-10-20232026-10-23T18:11:06+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-10_swiss-health-survey-2022-changes-in-mental-stress2026-10-23T18:11:06+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-10_access-consortiums-advanced-therapy-medicinal-products-working-group2026-10-23T18:11:05+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-10_first-electronic-product-information-epi-published-for-selected-human-medicines2026-10-23T18:11:05+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-03_the-differentiated-regulation-of-hemp-products-should-be-maintained2026-10-23T18:11:04+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-03_operation-pangea-xvi-international-campaign-against-falsified-and-illegally-imported-medicinal-products2026-10-23T18:11:04+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-03_revision-of-the-ordinance-on-medical-devices-meddo-and-ordinance-on-in-vitro-diagnostic-medical-devices-ivdo2026-10-23T18:11:03+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-03_swissmedic-confirmed-as-world-health-organization-listed-authority2026-10-23T18:11:03+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-11-03_medicinal-products-review-the-federal-office-of-public-health-reduces-prices2026-10-23T18:11:02+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-27_national-strategy-on-addiction-measures-against-online-addiction-are-sufficient2026-10-23T18:11:02+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-27_new-cost-containment-measures-will-come-into-effect-on-1-january-20242026-10-23T18:11:01+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-27_european-medicines-agency-ema-takes-further-steps-to-address-critical-shortages-of-medicines-in-the-eu2026-10-23T18:11:01+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-20_the-army-pharmacy-is-supplying-the-population-with-iodine-tablets2026-10-23T18:11:00+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-20_amendments-to-the-ordinance-on-health-insurance-opening-of-the-consultation-procedure2026-10-23T18:11:00+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-20_swissmedic-reviewed-swiss-importers2026-10-23T18:10:59+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-20_new-treatment-option-for-heavily-pre-treated-multiple-myeloma-patients2026-10-23T18:10:59+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-06_the-flu-vaccination-season-begins2026-10-23T18:00:36+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-06_health-risks-of-designer-drugs-further-psychoactive-substances-prohibited2026-10-23T18:00:35+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-06_swissmedic-journal-09-20232026-10-23T18:00:37+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-06_counterfeit-ozempic-diabetes-medication-in-circulation2026-10-23T18:00:36+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-06_revised-transparency-rules-for-the-eu-clinical-trials-information-system2026-10-23T18:00:37+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-10-06_the-dispute-over-the-crispr-cas9-basic-patents2026-10-23T18:00:38+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-29_federal-council-wants-to-maintain-security-of-supply-for-medical-devices2026-10-23T18:00:38+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-29_covid-19-federal-authorities-want-to-increase-use-of-scientific-knowledge2026-10-23T18:00:39+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-29_covid-19-federal-authorities-have-adequately-examined-covid-19-measures-for-constitutionality2026-10-23T18:00:39+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-29_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac2026-10-23T18:00:39+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-29_healthcare-medical-devices-2023---chapter-switzerland2026-10-23T18:30:24+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-22_federal-council-promotes-generics-and-access-to-essential-medicines2026-10-23T18:00:41+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-22_sharply-surging-costs-lead-to-significantly-higher-health-insurance-premiums-in-20242026-10-23T18:00:41+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-22_swissmedic-offers-scientific-advice-for-weight-of-evidence-approach-described-in-the-addendum-of-the-s1br1-guideline-on-testing-for-carcinogenicity-of-pharmaceuticals-of-the-international-council-for-harmonisation-of-technical-requirements2026-10-23T18:00:42+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-22_frequently-asked-questions-general-pharmacovigilance2026-10-23T18:00:42+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-22_swissmedic-approves-moderna-switzerland-gmbh-coronavirus-vaccine-spikevax-xbb-1-52026-10-23T18:00:43+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-22_swiss-pharmaceutical-reimbursement-and-pricing-the-ordinance-on-health-insurance-hio-and-the-ordinance-on-healthcare-benefits-krankenpflege-leistungsverordung-klv-will-change-as-of-january-20242026-10-23T18:30:24+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-15_daily-allowances-in-the-event-of-a-relapse-following-an-accident-not-originally-insured-under-the-accident-insurance-act-aia-the-federal-council-opens-the-consultation-procedure2026-10-23T18:00:44+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-15_changes-to-the-guidance-document-temporary-authorisation-of-human-medicinal-products2026-10-23T18:00:44+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-15_spikevax-european-medicines-agency-ema-recommends-approval-of-adapted-covid-19-vaccine-targeting-omicron-xbb-1-52026-10-23T18:00:45+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-15_european-medicines-agency-ema-recommends-non-renewal-of-authorisation-of-duchenne-muscular-dystrophy-medicine-translarna2026-10-23T18:00:45+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-15_european-medicines-agency-ema-recommends-non-renewal-of-authorisation-of-multiple-myeloma-medicine-blenrep2026-10-23T18:00:46+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-15_towards-a-permanent-collaboration-framework-for-european-medicine-agency-ema-and-health-technology-assessment-bodies2026-10-23T18:00:46+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-15_decision-c-3051-2021-dated-25-august-20232026-10-23T18:00:47+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-08_covid-19-vaccination-recommended-for-people-at-particular-risk-to-protect-against-severe-disease2026-10-23T18:00:47+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-08_outpatient-physiotherapy-whats-next2026-10-23T18:00:47+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-08_swiss-good-manufacturing-and-distribution-practice-swissgmdp-database2026-10-23T18:00:48+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-01_digisante-exchange-on-the-national-programme-for-digitisation-in-the-healthcare-sector2026-10-23T18:00:49+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-01_electronic-patient-record-epr-federal-council-submits-dispatch-on-transitional-financing-to-parliament2026-10-23T18:00:50+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-01_swissmedic-journal-08-20232026-10-23T18:00:50+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-01_complementary-and-herbal-medicines-containing-ethanol-in-paediatric-populations2026-10-23T18:00:51+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-01_implementation-of-the-full-declaration-for-homeopathic-and-anthroposophic-medicinal-products-without-indication2026-10-23T18:00:51+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-01_with-immediate-effect-covid-certificates-will-no-longer-be-issued2026-10-23T18:00:52+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-01_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-22026-10-23T18:00:51+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-09-01_smart-pills---qualification-under-the-swiss-legislation-on-therapeutic-products-innovation-in-the-field-of-tension-between-regulatory-scientific-and-economic-interdependencies2026-10-23T18:30:25+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-25_the-federal-office-of-public-health-foph-has-issued-new-information-letters-regarding-the-obligation-to-pass-on-discounts-under-the-health-insurance-act-hia2026-10-23T18:00:53+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-25_health-insurance-the-risk-compensation-statistics-will-be-expanded2026-10-23T18:00:54+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-25_health-technology-assessment-hta-programme-review-of-medical-services-curbs-healthcare-costs2026-10-23T18:00:54+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-25_treatment-recommendations-for-post-covid-19-disease2026-10-23T18:00:54+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-25_authorisation-application-submitted-for-coronavirus-vaccine-nuvaxovid-xbb-1-52026-10-23T18:00:55+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-25_comirnaty-european-medicines-agency-ema-recommends-approval-of-adapted-covid-19-vaccine-targeting-omicron-xbb-1-52026-10-23T18:00:55+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-18_advisory-board-digital-switzerland-exchange-on-national-program-for-the-digitization-of-the-healthcare-system2026-10-23T18:00:56+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-18_federal-council-to-launch-training-offensive-in-the-nursing-sector-in-mid-20242026-10-23T18:00:56+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-18_direct-healthcare-professional-communications-dhpc-valproate-depakine-depakine-chrono-valproate-chrono-sanofi-valproate-chrono-desitin-orfiril-long-orfiril-valproate-sandoz-convulex2026-10-23T18:00:57+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-18_evaluation-of-health-care-for-asylum-seekers2026-10-23T18:00:57+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-11_benchmarking-study-20222026-10-23T18:00:58+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-11_european-medicines-agency-ema-review-of-data-on-paternal-exposure-to-valproate2026-10-23T18:00:58+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-11_decision-9c-326-2023-dated-20-july-20232026-10-23T18:00:59+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-11_decision-9c-672-2021-dated-19-july-20232026-10-23T18:00:59+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-04_swissmedic-journal-07-20232026-10-23T18:01:00+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-08-04_swissmedic-gains-accreditation-for-good-manufacturing-practice-gmp-and-good-distribution-practice-gdp-in-the-field-of-advanced-therapy-medicinal-products-atmps2026-10-23T18:01:00+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-28_swissmedic-participation-in-the-european-medicines-agency-ema-open-initiative2026-10-23T18:01:01+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-28_decision-9c-256-2023-dated-18-july-20232026-10-23T18:01:01+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-21_new-blood-donation-criteria-for-men-who-have-sex-with-men2026-10-23T18:01:02+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-21_establishment-licence-for-dr-heinz-welti-ag---suspension-of-establishment-licence-at-bubendorf-site-lifted2026-10-23T18:01:02+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-21_mra-between-switzerland-and-the-usa-on-the-manufacturing-practice-for-medicinal-products-takes-effect2026-10-23T18:01:03+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-21_first-rsv-vaccine-to-protect-infants-up-to-6-months-of-age-and-older-adults2026-10-23T18:01:03+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-21_meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-17---20-july-20232026-10-23T18:01:03+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-21_paving-the-way-towards-coordinated-clinical-trials-in-public-health-emergencies-in-the-eu2026-10-23T18:01:04+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-14_triennial-review-of-medicines-sl-prices---lessons-learned-from-appeals-won-against-the-foph2026-10-23T18:30:26+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-14_pfizer-ag-submits-authorisation-application-for-coronavirus-vaccine-comirnaty-xbb-1-52026-10-23T18:01:05+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-14_meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-11---13-july-20232026-10-23T18:01:06+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-14_european-health-union---eu-steps-up-action-to-prevent-shortages-of-antibiotics-for-next-winter2026-10-23T18:01:05+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-14_reflection-paper-on-the-use-of-artificial-intelligence-in-the-lifecycle-of-medicines2026-10-23T18:01:06+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-14_open-framework-extended-to-a-wider-range-of-medicines2026-10-23T18:01:07+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-07_swissmedic-issues-warning-about-falsified-ozempic-pens2026-10-23T18:01:08+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-07_public-consultation-on-ich-reflection-paper-launched-in-switzerland2026-10-23T18:01:07+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-07_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-3---6-july-20232026-10-23T18:01:08+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-07_moderna-submits-authorisation-application-for-coronavirus-vaccine-spikevax-xbb-1-52026-10-23T18:01:08+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-07-07_ema-statement-on-ongoing-review-of-glp-1-receptor-agonists2026-10-23T18:01:09+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-30_the-federal-quality-commission-eidgenoessische-qualitaetskommission-eqk-promotes-best-practices-in-healthcare2026-10-23T18:01:10+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-30_addendum-11-2-of-the-european-pharmacopoeia-in-force2026-10-23T18:01:09+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-30_updated-version-of-the-substance-master-data-for-the-homant-software-available2026-10-23T18:01:10+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-30_software-homant-asia-for-the-authorisation-based-on-a-notification-notification-procedure-of-asian-medicinal-products-without-indication2026-10-23T18:01:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-30_revision-1-july-2023---updating-of-the-complementary-and-phytotherapeutic-products-ordinance-komplementaer-und-phytoarzneimittelverordnung-kpav-annexes2026-10-23T18:01:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-30_swissmedic-journal-06-20232026-10-23T18:01:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-30_nitrosamine-impurities-in-medicinal-products---swissmedic-sets-up-specialist-group2026-10-23T18:01:12+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-30_global-regulators-confirm-good-safety-profile-of-covid-19-vaccines2026-10-23T18:01:12+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-23_meeting-of-the-international-council-for-harmonisation-of-technical-requirements-for-pharmaceuticals-for-human-use-ich2026-10-23T18:01:13+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-23_meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-19---22-june-20232026-10-23T18:01:14+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-23_use-of-real-world-evidence-in-regulatory-decision-making---ema-publishes-review-of-its-studies2026-10-23T18:01:13+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-23_new-admission-restriction-in-four-medical-specialties-in-the-canton-of-zurich-will-not-be-implemented-for-the-time-being2026-10-23T18:01:14+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-23_the-electronic-patient-record-is-to-become-a-central-pillar-of-the-healthcare-system2026-10-23T18:01:15+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_ema-management-board---highlights-of-june-2023-meeting2026-10-23T18:01:16+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_federal-council-decides-to-revise-the-transplantation-ordinance-transplantationsverordnung2026-10-23T18:01:16+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_pollutants-in-the-body---federal-council-makes-clarifications-on-a-nationwide-health-study2026-10-23T18:01:17+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_new-benefits-in-basic-insurance-from-1-july-20232026-10-23T18:01:17+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_covid-19---final-report-on-the-impact-of-the-pandemic-on-health-care-costs2026-10-23T18:01:18+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_keep-batteries-consistently-out-of-the-reach-of-children2026-10-23T18:01:18+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_ordinance-on-tobacco-products-and-electronic-cigarettes-tabakprodukteverordnung-tabpv---opening-of-consultation2026-10-23T18:01:19+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_biosimilars-interchangeable-with-reference-products2026-10-23T18:01:19+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_medicinal-products-with-a-medical-device-component-combination-products---implementation-of-the-transitional-provisions-for-medical-devices2026-10-23T18:01:20+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_request-to-check-mandates-relating-to-ecm-certifications2026-10-23T18:01:20+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_changes-to-the-guidance-document-on-biosimilars2026-10-23T18:01:20+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-13-15-june-20232026-10-23T18:01:21+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_report---how-the-european-union-eu-ensured-safety-of-medicines-during-covid-192026-10-23T18:01:21+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-16_accelerating-clinical-trials-in-the-eu-act-eu---creating-a-better-environment-for-clinical-trials-through-collaboration2026-10-23T18:01:22+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_swiss-president-alain-berset-opens-76th-who-world-health-assembly2026-10-23T18:01:23+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_approval-of-health-insurance-premiums---increased-role-of-the-cantons2026-10-23T18:01:24+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_prohibition-of-advertising-for-tobacco-products-and-e-cigarettes-that-reaches-minors2026-10-23T18:01:23+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_simultaneous-review-of-applications-for-authorisation-of-veterinary-medicinal-products-by-swissmedic-and-the-uk-veterinary-medicines-directorate-vmd2026-10-23T18:01:24+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-15---16-may-20232026-10-23T18:01:25+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-22---25-may-20232026-10-23T18:01:25+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_global-regulators-agree-on-way-forward-to-adapt-covid-19-vaccines-to-emerging-variants2026-10-23T18:01:25+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_progress-with-eu-us-mutual-recognition-agreement-for-inspections-for-veterinary-medicines2026-10-23T18:01:26+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_swissmedic-vigilance-news-edition-30---may-20232026-10-23T18:01:27+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_confederation-and-cantons-launch-monitoring-of-the-implementation-of-the-long-term-care-initiative2026-10-23T18:01:26+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_changes-to-guidance-document-fast-track-authorisation-procedure-and-guidance-document-temporary-authorisation-for-human-medicinal-products2026-10-23T18:01:27+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_delayed-implementation-time-limits-for-replacement-changes2026-10-23T18:01:28+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_change-to-the-veterinary-medicinal-product-package-leaflet-template2026-10-23T18:01:28+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_swissmedic-journal-05-20232026-10-23T18:01:29+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_european-medicines-agency-ema-and-european-centre-for-disease-prevention-and-control-ecdc-statement-on-updating-covid-19-vaccines-to-target-new-sars-cov-2-virus-variants2026-10-23T18:01:29+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-06-09_decision-9c-508-2022-dated-15-may-20232026-10-23T18:01:30+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_federal-council-and-parliament-in-favour-of-extending-part-of-the-covid-19-act2026-10-23T18:01:31+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_access-consortium-offers-pipeline-meetings-to-pharmaceutical-and-biotechnology-companies2026-10-23T18:01:31+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_modification-of-the-drug-master-file-dmf-form2026-10-23T18:01:32+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_changes-to-the-guidance-document-gmp-compliance-by-foreign-manufacturers-and-the-form-declaration-by-the-responsible-person-for-foreign-manufacturers2026-10-23T18:01:32+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_changes-to-the-forms-for-new-authorisations-of-and-variations-to-human-and-veterinary-medicinal-products2026-10-23T18:01:33+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_transformation-of-swissmedic-platforms-tsp2026-10-23T18:01:33+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_swissmedic-journal-04-20232026-10-23T18:01:34+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_update-frequently-asked-questions-medical-devices---declarations-of-conformity2026-10-23T18:01:34+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_review-of-transparency-rules-for-the-eu-clinical-trials-information-system-ctis2026-10-23T18:01:35+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_hpc---becetamol-propylene-glycol2026-10-23T18:01:35+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_swiss-guideline-for-the-validation-and-routine-control-of-moist-heat-sterilisation-processes-in-hospitals2026-10-23T18:01:36+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_establishment-licence-of-amino-ag---manufacture-of-non-sterile-medicinal-products-permitted-again-at-the-gebenstorf-site2026-10-23T18:01:36+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_european-medicines-agency-ema-and-european-medicines-regulatory-network-lift-covid-19-business-continuity-status2026-10-23T18:01:36+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_medical-devices-swissmedic-hospital-inspections-2021-20222026-10-23T18:01:37+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_fluoroquinolone-antibiotics---reminder-of-measures-to-reduce-the-risk-of-side-effects2026-10-23T18:01:38+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-10---12-may-20232026-10-23T18:01:37+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_european-medicines-agency-ema-annual-report-2022-published2026-10-23T18:01:38+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_establishment-licence-for-dr-heinz-welti-ag---suspension-of-establishment-licence-at-gebenstorf-site-lifted2026-10-23T18:01:39+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_guidance-for-industry-to-prevent-and-mitigate-medicine-shortages2026-10-23T18:01:39+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-05-05_decision-9c-512-2022-dated-6-april-20232026-10-23T18:01:40+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_incorrectly-billed-covid-19-tests---federal-council-determined-to-uncover-all-abuses2026-10-23T18:01:41+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_ordinance-on-the-regulation-of-insurance-intermediary-activities-verordnung-ueber-die-regulierung-der-versicherungsvermittlertaetigkeit---opening-of-the-consultation-procedure2026-10-23T18:01:42+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_federal-council-takes-note-of-recommendations-for-foundations-under-private-law2026-10-23T18:01:42+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_federal-department-of-home-affairs-fdha-simplifies-access-to-pharmaceuticals2026-10-23T18:01:42+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_federal-council-extends-funding-programme-for-covid-19-drugs2026-10-23T18:01:43+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_research-on-humans---federal-council-wants-to-optimise-rules-for-human-research2026-10-23T18:01:43+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_counterfeit-bio-gen-cortical-bone-substitutes-from-bioteck-s-p-a2026-10-23T18:01:44+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_swissmedic-issues-warning-about-erectile-stimulants-from-online-sources2026-10-23T18:01:44+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_swissmedic-becomes-an-official-observer-in-the-international-medical-devices-regulators-forum-imdrf2026-10-23T18:01:45+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_swiss-biotech-day-on-24---25-april-in-basel2026-10-23T18:01:45+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_reducing-risks-to-human-and-animal-health-from-exposure-to-n-methyl-pyrrolidone-in-veterinary-medicines2026-10-23T18:01:46+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-11---14-april-20232026-10-23T18:01:46+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_single-arm-trials-as-pivotal-evidence-for-the-authorisation-of-medicines-in-the-eu2026-10-23T18:01:46+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-18---20-april-20232026-10-23T18:01:47+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-24---26-april-20232026-10-23T18:01:47+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_first-vaccine-to-protect-older-adults-from-respiratory-syncytial-virus-rsv-infection2026-10-23T18:01:48+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_decision-9c-534-2021-dated-4-april-20232026-10-23T18:01:48+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-21_new-publication-basel-landschaft-doctors-stop-unlawful---ruling-of-the-basel-landschaft-cantonal-court2026-10-23T18:30:28+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-14_new-publications-announcements-on-clinical-trials-with-medical-devices-and-performance-studies-with-in-vitro-diagnostic-medical-devices2026-10-23T18:01:50+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-14_swissmedic-approves-bivalent-pfizer-ltd-covid-19-original-omicron-ba-4-5-booster-dose-for-adults-aged-12-and-over2026-10-23T18:01:51+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-14_new-features-further-strengthen-priority-medicines-scheme-prime2026-10-23T18:01:50+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-14_regulatory-information---adjusted-fees-for-applications-to-ema-from-1-april-20232026-10-23T18:01:51+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-14_meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-27-30-march-20232026-10-23T18:01:52+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-06_swissmedic-journal-03-20232026-10-23T18:01:52+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-14_pharmacopoea-helvetica-12-and-addendum-11-1-of-the-european-pharmacopoeia-in-force2026-10-23T18:01:53+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-14_swissmedic-partially-lifts-suspensions-for-dr-heinz-welti-ag-distribution-licences-and-authorisations-are-valid-again-manufacturing-activities-still-suspended2026-10-23T18:01:53+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-04-14_combating-designer-drugs---11-individual-substances-added-to-the-narcotics-list2026-10-23T18:01:54+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_the-polluter-pays-principle-in-the-radiological-protection-act-rpa-is-clarified2026-10-23T18:01:55+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_federal-office-of-public-health-foph-strengthens-drug-supply2026-10-23T18:01:55+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_introduction-of-ectd-v4-02026-10-23T18:01:57+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_technical-update-regarding-the-certificate-of-a-pharmaceutical-product-cpp-order-form-and-issuance-of-a-new-version-of-the-guidance-request-cpp2026-10-23T18:01:56+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_swissmedic-partially-lifts-suspensions-for-amino-ag---medicinal-product-authorisations-are-valid-again-manufacturing-activities-still-suspended2026-10-23T18:01:56+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-13---16-march-20232026-10-23T18:01:58+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_ema-management-board-highlights-of-march-2023-meeting2026-10-23T18:01:57+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_advancing-regulatory-science-in-the-eu---mid-point-report-published2026-10-23T18:01:59+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_the-federal-council-aims-to-safeguard-the-supply-of-medical-devices2026-10-23T18:01:59+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_comirnaty-covid-10-vaccines-from-pfizer-ag-authorisation-without-special-conditions-approved2026-10-23T18:01:58+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_mdr-ivdr-amendment-equivalence-with-eu-regulation-on-medical-devices-ensured2026-10-23T18:02:00+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_darwin-eu-has-completed-its-first-studies-and-is-calling-for-new-data-partners2026-10-23T18:02:00+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_ema-recommends-approval-of-bimervax-as-a-covid-19-booster-vaccine2026-10-23T18:02:01+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-03-31_decision-9c-269-2022-dated-31-january-20232026-10-23T18:02:01+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_around-80-foreign-delegations-met-in-montreux-to-take-action-on-patient-safety2026-10-23T18:02:02+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_new-swissmedic-mobile-technologies-guidance-document-for-human-and-veterinary-medicinal-products2026-10-23T18:02:02+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_changes-to-the-swissmedic-guidance-document-product-information-for-human-medicinal-products2026-10-23T18:02:03+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_authorizations-of-human-medicinal-products-with-a-new-active-substance-and-additional-indications-20222026-10-23T18:02:04+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-20-23-february-20232026-10-23T18:02:03+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_ema-pilots-scientific-advice-for-certain-high-risk-medical-devices2026-10-23T18:02:04+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_dispensing-of-pharmaceutically-produced-heroin-is-simplified2026-10-23T18:02:05+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_covid-19-vaccination-now-only-recommended-for-certain-people-with-risk-factors2026-10-23T18:02:06+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_accelerated-reimbursement-of-a-cancer-drug2026-10-23T18:02:05+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_incorrectly-billed-covid-19-tests2026-10-23T18:02:06+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_swissmedic-journal-02-20232026-10-23T18:02:07+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_swissmedic-issues-unlimited-authorisation-for-booster-dose-of-modernas-bivalent-covid-19-original-omicron-ba-4-5-vaccine2026-10-23T18:02:07+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-24_qr-codes-for-medicines---new-guidance2026-10-23T18:30:30+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-17_veterinary-medicines-ema-highlights-of-20222026-10-23T18:02:09+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-17_organ-transplantation-federal-council-wants-to-increase-safety2026-10-23T18:02:09+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-17_public-consultation-on-ich-guideline-m13-bioequivalence-for-immediate-release-solid-oral-dosage-forms-launched-in-switzerland2026-10-23T18:02:10+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-17_modifications-to-guidance-document-formal-requirements2026-10-23T18:02:10+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-17_meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-6-9-february-20232026-10-23T18:02:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-17_emas-safety-committee-starts-safety-review-of-pseudoephedrine-containing-medicines2026-10-23T18:02:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-17_hpc-toxicity-of-flunixin-containing-veterinary-drugs-to-necrophagous-birds2026-10-23T18:02:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-17_human-medicines-highlights-of-20222026-10-23T18:02:12+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-17_global-ministerial-patient-safety-summit2026-10-23T18:02:12+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-17_meeting-highlights-from-the-committee-for-veterinary-medicinal-products-14-16-february-20232026-10-23T18:02:13+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-17_decision-9c-615-2021-dated-31-january-20232026-10-23T18:02:13+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-10_tightening-up-on-drug-supply-the-national-economic-supply-is-considering-further-measures2026-10-23T18:02:14+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-10_certificate-of-a-pharmaceutical-product-in-the-new-who-format2026-10-23T18:02:14+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-10_swissmedic-journal-01-20232026-10-23T18:02:15+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-10_use-of-clinical-trials-information-system-becomes-mandatory-for-new-clinical-trial-applications-in-the-eu2026-10-23T18:02:15+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-10_meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-23-26-january-2023-for-more-information-see-here2026-10-23T18:02:16+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-10_public-consultation-on-a-multi-stakeholder-platform-to-improve-clinical-trials-in-the-eu2026-10-23T18:02:16+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-10_actions-to-support-the-development-of-medicines-for-children2026-10-23T18:02:17+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-02-10_decision-c-688-21-dated-7-february-20232026-10-23T18:02:17+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-20_decision-c-3188-2019-dated-19-december-20222026-10-23T18:02:18+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-20_changes-to-the-guidance-documents-fast-track-authorisation-procedure-and-temporary-authorisation-for-human-medicinal-products2026-10-23T18:02:18+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-20_changes-to-the-guidance-document-authorisation-of-human-medicinal-products-under-art-13-tpa2026-10-23T18:02:19+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-20_assessment-of-human-dietary-exposure-to-residues-of-veterinary-medicines-in-the-eu2026-10-23T18:02:19+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-20_the-federal-government-intervenes-in-the-planted-chicken-dispute2026-10-23T18:30:30+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-20_decision-c-3189-2019-c-3190-2019-dated-19-december-20222026-10-23T18:02:20+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-20_decision-2c-49-2022-dated-8-december-20222026-10-23T18:02:21+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-13_delay-in-issuance-of-new-insurance-cards2026-10-23T18:02:22+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-13_covid-19-epidemiological-situation-does-not-presently-warrant-compulsory-testing-for-travellers-from-china2026-10-23T18:02:22+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-13_increase-in-illegal-imports-of-nasal-sprays-and-laxatives-swissmedic-warns-against-the-risk-of-dependence2026-10-23T18:02:23+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-13_dealing-with-certification-gaps-of-medical-devices-mdcg-2022-182026-10-23T18:02:23+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-13_swissmedic-journal-12-222026-10-23T18:02:24+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-13_covid-19-treatments-authorised2026-10-23T18:02:24+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-13_covid-19-vaccines-authorised2026-10-23T18:02:25+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-13_food-for-special-medical-purposes-fsmp-new-specific-cjeu-requirements2026-10-23T18:30:31+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-13_decision-c-5620-2020-dated-22-december-20222026-10-23T18:02:26+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-06_arrange-it-dont-postpone-it-organ-donation2026-10-23T18:02:26+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-06_updated-faq-on-medical-devices2026-10-23T18:02:27+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-06_changes-to-swisspar-hmv4-guidance-document2026-10-23T18:02:27+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-06_changes-to-template-for-information-for-healthcare-professionals-for-vmp-changes-to-template-for-information-for-healthcare-professionals-for-immunological-vmp2026-10-23T18:02:28+02:00weekly0.5https://www.lifesciencelaw.ch/news/2023-01-06_new-edition-of-the-european-pharmacopoeia-enters-into-force2026-10-23T18:02:28+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-23_covid-19-remuneration-of-vaccinations-and-passing-on-of-vaccine-doses-in-20232026-10-23T18:02:29+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-23_federal-council-approves-collective-agreements-in-the-outpatient-sector2026-10-23T18:02:29+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-23_federal-council-supports-the-non-remuneration-and-a-ban-on-discrimination-in-blood-donation2026-10-23T18:02:30+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-23_flat-rates-in-the-ophthalmology-sector-collective-agreement-approved-until-the-end-of-20232026-10-23T18:02:30+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-23_covid-19-individual-pandemic-control-measures-to-be-extended2026-10-23T18:02:31+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-23_update-of-swissmedics-and-swissethics-position-paper-on-decentralized-clinical-trials-dcts-with-medicinal-products-in-switzerland2026-10-23T18:02:32+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-23_facilitating-decentralised-clinical-trials-in-the-eu2026-10-23T18:02:31+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-23_covid-19-vaccines-authorized2026-10-23T18:02:32+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_lgbt-persons-report-finds-health-inequalities2026-10-23T18:02:33+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_federal-council-approves-swissmedics-strategic-goals-for-2023-20262026-10-23T18:02:33+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_reporting-suspected-adverse-reactions-following-vaccination-against-mpox-monkeypox2026-10-23T18:02:33+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_clarification-of-terminology-for-combination-products-medicinal-products-with-a-medical-device-component---current-status-and-revision-of-specification-documents2026-10-23T18:02:34+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_public-health-advice-during-covid-19-pandemic2026-10-23T18:02:35+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_treatments-and-vaccines-for-covid-192026-10-23T18:02:34+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_covid-19-treatments-authorised-22026-10-23T18:02:35+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_covid-19-vaccines-authorised-22026-10-23T18:02:36+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_covid-19-vaccines-authorized-22026-10-23T18:02:36+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_covid-19-vaccines-authorized-32026-10-23T18:02:37+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_etf-warns-that-monoclonal-antibodies-may-not-be-effective-against-emerging-strains-of-sars-cov-22026-10-23T18:02:37+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-6-8-december-20222026-10-23T18:02:38+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_epsco-meeting-eu-commission-proposes-selective-amendments-to-mdr-ivdr2026-10-23T18:02:38+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_reports-of-adverse-reactions-to-veterinary-medicinal-products-20212026-10-23T18:02:39+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_swissmedic-journal-11-20222026-10-23T18:02:39+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_ema-recommends-withdrawal-of-pholcodine-medicines-from-eu-market2026-10-23T18:02:39+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_the-etf-concludes-that-bivalent-original-omicron-ba-4-5-mrna-vaccines-may-be-used-for-primary-vaccination2026-10-23T18:02:40+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_ecdc-and-ema-collaborate-on-vaccine-safety-and-effectiveness-monitoring-studies2026-10-23T18:02:40+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_new-virus-discovered-in-swiss-ticks2026-10-23T18:02:41+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_9c-12-2022-dated-26-october-20222026-10-23T18:02:41+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-16_vb-2022-00270-dated-10-november-20222026-10-23T18:02:42+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_genetic-testing-in-switzerland-to-be-newly-regulated2026-10-23T18:02:42+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_cannabis-shall-be-controlled-and-legally-accessible-but-not-promoted2026-10-23T18:02:43+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_outpatient-before-inpatient-confederation-and-cantons-now-to-keep-only-one-list2026-10-23T18:02:43+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_admission-of-physicians-the-regional-care-supply-rates-by-specialty-have-been-published2026-10-23T18:02:44+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_reports-of-suspected-adverse-reactions-to-covid-19-vaccines-in-switzerland---update-282026-10-23T18:02:44+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_public-consultation-on-ich-guideline-q5ar2-viral-safety-evaluation-of-biotechnology-products-derived-from-cell-lines-of-human-or-animal-origin-launched-in-switzerland2026-10-23T18:02:45+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_public-consultation-on-ich-guideline-m11-clinical-electronic-structured-harmonised-protocol-cesharp-launched-in-switzerland2026-10-23T18:02:45+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_meeting-of-the-international-council-for-harmonisation-of-technical-requirements-for-pharmaceuticals-for-human-use-ich-22026-10-23T18:02:46+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_expansion-of-scope-of-temporary-authorisations2026-10-23T18:02:46+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_changes-to-template-for-information-for-healthcare-professionals-vmp-changes-to-template-for-package-leaflet-vmp2026-10-23T18:02:47+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_out-of-stock---covid-19---authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update2026-10-23T18:02:47+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_covid-19-vaccines-authorised-32026-10-23T18:02:48+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_covid-19-vaccines-authorised-42026-10-23T18:02:48+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_covid-19-vaccines-authorised-52026-10-23T18:02:49+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_commercial-dishwashers-destroy-protective-layer-in-gut2026-10-23T18:02:49+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_covid-19-federation-and-cantons-want-to-continue-working-closely-with-science2026-10-23T18:02:50+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_several-cost-containment-measures-to-come-into-force-on-1-january-20232026-10-23T18:02:50+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_preventing-antimicrobial-resistance-together2026-10-23T18:02:51+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_swissmedic-responsible-for-animal-vaccines-from-1-1-20232026-10-23T18:02:51+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_swissmedic-vigilance-news-edition-29---november-20222026-10-23T18:02:52+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_moderna-applies-to-swissmedic-for-authorisation-of-a-second-bivalent-covid-19-vaccine2026-10-23T18:02:52+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_best-practices-to-fight-antimicrobial-resistance2026-10-23T18:02:53+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_new-quality-innovation-expert-group-qig-supports-medicine-innovation-in-the-eu2026-10-23T18:02:53+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_darwin-eu-welcomes-first-data-partners2026-10-23T18:02:54+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_treatments-and-vaccines-for-covid-19-22026-10-23T18:02:54+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_zurich-researchers-optimise-mri-technology2026-10-23T18:02:54+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-12-02_covid-19-the-spike-protein-is-no-longer-the-only-target2026-10-23T18:02:55+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-18_covid-19-vaccines-authorised-62026-10-23T18:02:56+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-18_covid-19-vaccines-authorised-72026-10-23T18:02:57+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-18_meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-7-10-november-20222026-10-23T18:02:58+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-18_switzerland-must-remain-a-world-leader-in-the-chemical-and-pharmaceutical-industry2026-10-23T18:02:57+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-18_how-covid-19-causes-neurological-damage2026-10-23T18:02:58+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-18_a-chip-to-replace-animal-testing2026-10-23T18:02:59+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-11_monkeypox-vaccine-arrived2026-10-23T18:03:00+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-11_federal-council-adopts-framework-agreement-on-the-reimbursement-of-innovative-cancer-therapies2026-10-23T18:03:01+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-11_investigation-into-the-procurement-of-covid-19-vaccines-confirms-previous-findings2026-10-23T18:03:00+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-11_measures-of-the-strategy-on-antibiotic-resistance-star-producing-results-use-of-antibiotics-decreases2026-10-23T18:03:03+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-11_covid-19-vaccines-authorised-82026-10-23T18:03:03+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-11_covid-19-vaccines-authorised-102026-10-23T18:03:04+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-11_covid-19-vaccines-authorised-92026-10-23T18:03:04+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-11_covid-19-vaccines-authorised-112026-10-23T18:03:05+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-11_safety-of-covid-19-vaccines2026-10-23T18:03:05+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-04_strategy-against-resistance-federal-council-wants-to-examine-the-individual-dispensing-of-antibiotics-in-greater-depth2026-10-23T18:03:06+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-04_the-federal-council-wants-to-continue-the-current-measures-against-waste-of-medicines2026-10-23T18:03:06+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-04_reduction-of-prices-of-medicines-leads-to-savings-of-at-least-250-million-swiss-francs-from-2020-to-20222026-10-23T18:03:07+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-04_the-new-pharmacopoea-helvetica-122026-10-23T18:03:07+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-04_out-of-stock---covid-19---authorisations-for-the-temporary-import-and-distribution-of-human-medicines---update-22026-10-23T18:03:08+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-04_reports-of-formation-of-bubbles-in-a-batch-of-the-covid-19-vaccine-comirnaty-bivalent-original-omicron-ba-1---risks-currently-being-investigated2026-10-23T18:03:08+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-04_ema-recommends-measures-to-minimise-risk-of-serious-side-effects-with-janus-kinase-inhibitors-for-chronic-inflammatory-disorders2026-10-23T18:03:09+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-04_ema-confirms-recommendation-to-withdraw-marketing-authorisations-for-amfepramone-medicines-share2026-10-23T18:03:09+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-11-04_covid-19-vaccines-authorised-122026-10-23T18:03:10+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-28_introduction-of-a-specialist-examination-for-medical-practice-assistants-has-proven-to-work-well2026-10-23T18:03:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-28_covid-19-vaccines-authorised-132026-10-23T18:03:11+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-28_treatments-and-vaccines-for-covid-19-32026-10-23T18:03:12+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-28_covid-19-vaccines-authorised-142026-10-23T18:03:12+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-21_monkeypox-vaccine-federal-government-signs-contract-with-manufacturing-company2026-10-23T18:03:13+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-21_quit-smoking-together-registration-for-smoke-free-month-is-open2026-10-23T18:03:13+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-21_covid-19-expired-vaccine-disposal2026-10-23T18:03:13+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-21_covid-19-vaccines-authorised-162026-10-23T18:03:14+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-21_covid-19-vaccines-authorised-152026-10-23T18:03:14+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-21_covid-19-extraordinary-meeting-of-chmp2026-10-23T18:03:15+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-21_covid-19-vaccines-authorised-182026-10-23T18:03:16+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-21_covid-19-vaccines-authorised-172026-10-23T18:03:15+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_instructions-to-the-slkk-health-insurance2026-10-23T18:03:16+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_covid-19-booster-vaccination-from-10-october-20222026-10-23T18:03:17+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_new-regulations-for-unpaid-health-insurance-premiums-opening-of-the-consultation-procedure2026-10-23T18:03:18+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_start-of-the-flu-vaccination-season2026-10-23T18:03:17+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_link-between-fertility-and-covid-19-vaccination-investigated2026-10-23T18:03:18+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_announcements-on-market-control-issues2026-10-23T18:03:19+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_annual-vaccinovigilance-report2026-10-23T18:03:19+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_swissmedic-approves-bivalent-covid-19-booster-vaccine-from-pfizer2026-10-23T18:03:20+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_covid-19-vaccines-authorised-192026-10-23T18:03:21+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_safety-of-covid-19-vaccines-22026-10-23T18:03:20+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_covid-19-treatments-authorised-32026-10-23T18:03:21+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_covid-19-vaccines-authorised-202026-10-23T18:03:22+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_covid-19-vaccines-authorised-212026-10-23T18:03:22+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-10-14_covid-19-treatments-authorised-42026-10-23T18:03:22+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-30_health-insurance-strong-cost-increase-leads-to-higher-premiums-in-20232026-10-23T18:03:23+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-30_evaluation-of-the-crisis-organisation-in-the-first-phase-of-the-covid-19-pandemic2026-10-23T18:03:23+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-30_update-on-the-replacement-of-the-medical-professions-register-medreg-by-the-new-health-pro-fessions-platform-healthreg2026-10-23T18:03:24+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-30_covid-19-vaccines-authorised-222026-10-23T18:03:24+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-23_adoption-of-revised-laws-on-human-genetic-testing2026-10-23T18:03:25+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-23_digital-transformation-in-the-healthcare-sector2026-10-23T18:03:26+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-23_overall-emergency-exercise-2022-with-leibstadt-nuclear-power-plant2026-10-23T18:03:25+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-23_application-for-authorisation-of-a-second-bivalent-covid-19-vaccine2026-10-23T18:03:26+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-16_covid-19-vaccination-recommendations-autumn-20222026-10-23T18:03:27+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-16_swiss-database-on-medical-devices2026-10-23T18:03:27+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-16_potential-nitrosamine-contamination---harmonised-implementation-update2026-10-23T18:03:28+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-16_covid-19-vaccines-authorised-232026-10-23T18:03:28+02:00weekly0.5https://www.lifesciencelaw.ch/news/2022-09-16_covid-19-vaccines-authorised-242026-10-23T18:03:29+02:00weekly0.5